REFERENCES
  1. Lam CG, Howard SC, Bouffet E, Pritchard-Jones K. Science and health for all children with cancer. Science. 2019; 363:1182-1186.
  2. Howard SC, Davidson A, Luna-Fineman S, et al. A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: the Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP). Pediatr Blood Cancer. 2018; 64:e26879.
  3. Sullivan M, Bouffet E, Rodriguez- Galindo C, et al. The COVID-19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer. 2020; 67:e28409.
  4. Bouffet E, Challinor J, Sullivan M, Biondi A, et al. Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences. Pediatr Blood Cancer. 2020:e28327
  5. Gampel B, Troullioud Lucas AG, Broglie L, Gartrell-Corrado RD, et al. COVID-19 disease in New York City pediatric hematology and oncology patients. Pediatr Blood Cancer. 2020 Sep;67: e28420
  6. de Rojas T, Perez Martinez A, Cela E, et al. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer. 2020;67:e28397.
  7. Yigenoglu TN, Ata N, Altuntas F, et al. The outcome of COVID- 19 in patients with hematological malignancy. J Med Virol. 2021;93:1099-1104
  8. Boulad F, Kamboj M, Bouvier N, et al. COVID-19 in children with cancer in New York City. JAMA Oncol. 2020;6:1459-1460
  9. Hrusak O, Kalina T, Wolf J, et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Eur J Cancer. 2020; 132:11–6
  10. Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020;20: 669-677
  11. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062
  12. Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136:2881-2892
  13. Hamdy R, El-Mahallawy H, Ebeid E. COVID-19 infection in febrile neutropenic pediatric hematology oncology patients. Pediatr Blood Cancer. 2021 ;68:e28765
  14. de Rojas T, Pérez-Martínez A, Cela E, Baragaño M, et al. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer. 2020 ;67:e28397.
  15. CDC COVID-19 Response Team. Coronavirus disease 2019 in children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep . 2020;69:422
  16. Guo, CX., He, L., Yin, JY. et al.  Epidemiological and clinical features of pediatric COVID-19. BMC Med  18,  250 (2020).
  17. Montoya J, Ugaz C, Alarcon S, Maradiegue E, García J, Díaz R, Zapata A, Chávez S, Morales R, Ordoñez K, Hernandez E, Reaño R, Gutierrez C, Vargas MP, Sanchez K, Valdiviezo C, Maza I, Rojas N, Moore C, León E, Vásquez L. COVID-19 in pediatric cancer patients in a resource-limited setting: National data from Peru. Pediatr Blood Cancer. 2020 Jul 22:e28610..